Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLixte Biotechnology Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Lixte Biotechnology Holdings, Inc. Earnings Date And Information
Lixte Biotechnology Holdings, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Lixte Biotechnology Holdings, Inc. has generated $-3 earnings per share over the last year ($-2.66 diluted earnings per share) and currently has a price-to-earnings ratio of -0.62. Lixte Biotechnology Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Lixte Biotechnology Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | N/A | -$0.44 | N/A | $0 | $0 |
| 08/08/2024 | Q2 2024 | N/A | -$0.45 | N/A | $0 | $0 |
| 05/09/2024 | Q1 2024 | N/A | -$0.43 | N/A | N/A | $0 |
| 03/19/2024 | Q4 2023 | N/A | -$0.46 | N/A | N/A | $0 |
| 11/09/2023 | Q3 2023 | N/A | -$0.49 | N/A | N/A | $0 |
| 08/09/2023 | Q2 2023 | N/A | -$1.00 | N/A | N/A | $0 |
| 05/10/2023 | Q1 2023 | N/A | -$0.82 | N/A | N/A | $0 |
| 03/29/2023 | Q4 2022 | N/A | -$0.98 | N/A | N/A | $0 |
| 11/08/2022 | Q3 2022 | N/A | -$0.89 | N/A | N/A | $0 |
| 08/10/2022 | Q2 2022 | N/A | -$0.95 | N/A | N/A | $0 |
| 05/11/2022 | Q1 2022 | N/A | -$1.21 | N/A | N/A | $0 |
| 03/21/2022 | Q4 2021 | N/A | -$1.48 | N/A | N/A | $0 |
| 11/10/2021 | Q3 2021 | N/A | -$0.90 | N/A | N/A | $0 |
| 08/10/2021 | Q2 2021 | N/A | -$1.27 | N/A | N/A | $0 |
| 05/12/2021 | Q1 2021 | N/A | -$1.35 | N/A | N/A | $0 |
| 03/26/2021 | Q4 2020 | N/A | -$0.78 | N/A | N/A | $0 |
| 11/10/2020 | Q3 2020 | N/A | -$1.43 | N/A | N/A | $0 |
| 08/10/2020 | Q2 2020 | N/A | -$0.33 | N/A | N/A | $0 |
| 05/11/2020 | Q1 2020 | N/A | -$0.34 | N/A | N/A | $0 |
| 03/25/2020 | Q4 2019 | N/A | -$0.29 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lixte Biotechnology Holdings, Inc. Earnings: FAQ's
Lixte Biotechnology Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based offlast year's report dates.
The conference call for Lixte Biotechnology Holdings, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Lixte Biotechnology Holdings, Inc.'s latest earnings report can be read online.
Lixte Biotechnology Holdings, Inc. (:LIXT) has a recorded net income of $-5,087,029.Lixte Biotechnology Holdings, Inc. has generated $-2.66 earnings per share over the last four quarters.
Lixte Biotechnology Holdings, Inc. (:LIXT) has a price-to-earnings ratio of -0.62 and price/earnings-to-growth ratio is -0.23.